[1] Makdisi G, Wang I W. Extra Corporeal Membrane Oxygenation (ECMO) review of a lifesaving technology[J]. J Thorac Dis, 2015, 7(7): E166-E176. [2] McCarthy F H, Mcdermott K M, Kini V, et al. Trends in U.S. extracorporeal membrane oxygenation use and outcomes: 2002-2012[J]. Semin Thoracic Cardiovasc Surg, 2015, 27(2): 81-88. [3] Cho H W, Song I A, Oh T K. Trends in extracorporeal membrane oxygenation treatment from 2005 to 2018 in South Korea[J]. Perfusion, 2021, 20: 2676591211018130. [4] Thiagarajan R R, Barbaro R P, Rycus P T, et al. Extracorporeal life support organization registry international report 2016[J]. ASAIO J, 2017, 63(1): 60-67. [5] Savarimuthu S, Binsaeid J, Harky A. The role of ECMO in COVID-19: can it provide rescue therapy in those who are critically ill?[J]. J Card Surg, 2020, 35(6): 1298-1301. [6] Sutter R, Tisljar K, Marsch S. Acute neurologic complications during extracorporeal membrane oxygenation[J]. Crit Care Med, 2018, 46(9): 1506-1513. [7] Migdady I, Rice C, Deshpande A, et al. Brain injury and neurologic outcome in patients undergoing extracorporeal cardiopulmonary resuscitation[J]. Criti Care Med, 2020, 48(7): e611-e619. [8] Shoskes A, Migdady I, Rice C, et al. Brain injury is more common in venoarterial extracorporeal membrane oxygenation than venovenous extracorporeal membrane oxygenation: a systematic review and meta-analysis[J]. Crit Care Med, 2020, 48(12): 1799-1808. [9] Cho S M, Farrokh S, Whitman G, et al. Neurocritical care for extracorporeal membrane oxygenation patients[J]. Crit Care Med, 2019, 47(12): 1773-1781. [10] Cho S M, Geocadin R G, Caturegli G, et al. Understanding characteristics of acute brain injury in adult extracorporeal membrane oxygenation: an autopsy study[J]. Crit Care Med, 2020, 48(6): e532-e536. [11] Lorusso R, Barili F, Mauro M D, et al. In-hospital neurologic complications in adult patients undergoing venoarterial extracorporeal membrane oxygenation[J]. Crit Care Med, 2016, 44(10): e964-e972. [12] Honore P M, Barreto Gutierrez L, Kugener L, et al. Risk of harlequin syndrome during bi-femoral peripheral VA-ECMO: should we pay more attention to the watershed or try to change the venous cannulation site?[J]. Crit Care, 2020, 24(1): 450. [13] Luyt C E, Bréchot N, Demondion P, et al. Brain injury during venovenous extracorporeal membrane oxygenation[J]. Intensive Care Med, 2016, 42(5): 897-907. [14] Cho S M, Ritzl E K. Neurological prognostication using electroencephalogram in adult veno-arterial extracorporeal membrane oxygenation: limitations and recommendations[J]. Neurocrit Care, 2020, 33(3): 652-654. [15] Bembea M M, Felling R, Anton B, et al. Neuromonitoring during extracorporeal membrane oxygenation[J]. Pediatr Crit Care Med, 2015, 16(6): 558-564. [16] Devlin J W, Skrobik Y, Gélinas C, et al. Clinical practice guidelines for the prevention and management of pain, agitation/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU[J]. Crit Care Med, 2018, 46(9): e825-e873. [17] Cho S M, Ziai W, Mayasi Y, et al. Noninvasive neurological monitoring in extracorporeal membrane oxygenation[J]. ASAIO J, 2020, 66(4): 388-393. [18] Magalhaes E R B, Reuter J C, Wanono R, et al. Early EEG for prognostication under venoarterial extracorporeal membrane oxygenation[J]. Neurocrit Care, 2020, 33(3): 688-694. [19] Westhall E, Rossetti A O, van Rootselaar A F, et al. Standardized EEG interpretation accurately predicts prognosis after cardiac arrest[J]. Neurology, 2016, 86(16): 1482-1490. [20] Cho S M, Geocadin R G, White B, et al. Neuropathological findings in comatose patients with venoarterial extracorporeal membrane oxygenation[J]. Int Artif Organs, 2020, 43(9): 614-619. [21] Hunt M F, Clark K T, Whitman G, et al. The use of cerebral nirs monitoring to identify acute brain injury in patients with VA-ECMO[J]. J Intensive Care Med, 2020, 15:885066620966962. [22] Kavi T, Esch M, Rinsky B, et al. Transcranial doppler changes in patients treated with extracorporeal membrane oxygenation[J]. J Stroke Cerebrovasc Dis, 2016, 25(12): 2882-2885. [23] Melmed K R, Schlick K H, Rinsky B, et al. Assessing cerebrovascular hemodynamics using transcranial doppler in patients with mechanical circulatory support devices[J]. J Neuroimaging, 2020, 30(3): 297-302. [24] O′ Brien N F, Buttram S D W, Maa T, et al. Cerebrovascular physiology during pediatric extracorporeal membrane oxygenation[J]. Pediatr Criti Care Med, 2019, 20(2): 178-186. [25] Grinspan Z M, Pon S, Greenfield J P, et al. multimodal monitoring in the pediatric intensive care unit: new modalities and informatics challenges[J]. Semin Pediatr Neuro, 2014, 21(4): 291-298. [26] Khan I, Rehan M, Parikh G, et al. Regional cerebral oximetry as an indicator of acute brain injury in adults undergoing veno-arterial extracorporeal membrane oxygenation-A Prospective Pilot Study[J]. Front Neurol, 2018, 9:993. [27] Pozzebon S, Blandino Ortiz A, Franchi F, et al. Cerebral near-infrared spectroscopy in adult patients undergoing veno-arterial extracorporeal membrane oxygenation[J]. Neurocrit Care, 2018, 29(1): 94-104. [28] Tsou P Y, Garcia A V, Yiu A, et al. Association of cerebral oximetry with outcomes after extracorporeal membrane oxygenation[J]. Neurocrit Care, 2020, 33(2): 429-437. [29] Floerchinger B, Philipp A, Foltan M, et al. Neuron-specific enolase serum levels predict severeneuronal injury after extracorporeal life support in resuscitation[J]. Eur J Cardiothoracic Surgery, 2014, 45(3): 496-501. [30] Nguyen D N, Huyghens L, Wellens F, et al. Serum S100B protein could help to detect cerebral complications associated with extracorporeal membrane oxygenation (ECMO)[J]. Neurocrit Care, 2014, 20(3): 367-374. [31] Bembea M M, Rizkalla N, Freedy J, et al. Plasma biomarkers of brain injury as diagnostic tools and outcome predictors after extracorporeal membrane oxygenation[J]. Crit Care Med, 2015, 43(10): 2202-2211. [32] Cho S M, Canner J, Chiarini G, et al. Modifiable risk factors and mortality from ischemic and hemorrhagic strokes in patients receiving venoarterial extracorporeal membrane oxygenation: results from the extracorporeal life support organization registry[J]. Criti Care Med, 2020, 48(10): e897-e905. [33] Patel M, Altshuler D, Lewis T C, et al. Sedation requirements in patients on venovenous or venoarterial extracorporeal membrane oxygenation[J]. Ann Pharmacother, 2020, 54(2): 122-130. [34] Marhong J D, Debacker J, Viau-Lapointe J, et al. Sedation and mobilization during venovenous extracorporeal membrane oxygenation for acute respiratory failure[J]. Criti Care Med, 2017, 45(11): 1893-1899. |